|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 9/20 | (2006.01) |
| A61K 9/14 | (2006.01) | ||
| A61K 47/14 | (2006.01) | ||
| A61K 47/22 | (2006.01) | ||
| A61K 31/513 | (2006.01) | ||
| A61K 31/427 | (2006.01) |
| (11) | Number of the document | 2046298 |
| (13) | Kind of document | T |
| (96) | European patent application number | 07787658.9 |
| Date of filing the European patent application | 2007-07-17 | |
| (97) | Date of publication of the European application | 2009-04-15 |
| (45) | Date of publication and mention of the grant of the patent | 2016-11-30 |
| (46) | Date of publication of the claims translation | 2017-03-27 |
| (86) | Number | PCT/EP2007/057392 |
| Date | 2007-07-17 |
| (87) | Number | WO 2008/009689 |
| Date | 2008-01-24 |
| (30) | Number | Date | Country code |
| 06015076 | 2006-07-19 | EP | |
| 832074 P | 2006-07-19 | US |
| (72) |
ROSENBERG, Jörg, DE
BREITENBACH, Jörg, DE
MARSH, Kennan, US
LIEPOLD, Bernd, DE
SCHMIDT, Christoph, DE
LANDER, Ute, DE
|
| (73) |
AbbVie Deutschland GmbH & Co KG,
Max-Planck-Ring 2a, 65205 Wiesbaden,
DE
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Farmacinė vaisto forma, turinti farmaciniu požiūriu priimtiną soliubilizuojančią kompoziciją |
| PHARMACEUTICAL DOSAGE FORM CONTAINING PHARMACEUTICALLY ACCEPTABLE SOLUBILIZING COMPOSITION |
| Payment date | Validity (years) | Amount | |
| 2019-07-04 | 13 | 289.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2020-07-17 |